✦ LIBER ✦

A Phase I, open-label, dose escalation study of afatinib, in a 3-week-on/1-week-off schedule in patients with advanced solid tumors

✍ Scribed by John Marshall,Jimmy Hwang,Ferry A. L. M. Eskens…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I, open-label, dose-escalation s

✍ Michael S. Gordon,David S. Mendelson,Mitchell Gross… 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 200 KB

Phase I and pharmacokinetic study of lon

✍ Carlos Castaneda; Kellen L. Meadows; Roxanne Truax; Michael A. Morse; Scott H. K 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 358 KB

A phase 1 trial dose-escalation study of

✍ Kirschbaum, M H; Synold, T; Stein, A S; Tuscano, J; Zain, J M; Popplewell, L; Ka 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 213 KB

Phase 1, open-label, dose-escalation, an

✍ Bendell, Johanna C.; Hong, David S.; Burris, Howard A.; Naing, Aung; Jones, Suza 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 189 KB

38 POSTER Phase I and pharmacological st

✍ F.A.L.M. Eskens; M.J.A. de Jonge; L. van Doorn; T. Isoe; K. Hayashi; S. Hussain; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A phase I dose escalation study of BIBW

✍ Eskens, F A L M; Mom, C H; Planting, A S T; Gietema, J A; Amelsberg, A; Huisman, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 173 KB